ClinicalTrials.Veeva

Menu

Influence of Manual Diaphragm Release on Pulmonary Functions in Women With COVID-19

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

COVID-19 Pneumonia

Treatments

Other: manual therapy
Other: breathing exercise and prone position alone

Study type

Interventional

Funder types

Other

Identifiers

NCT05903144
PFT in COVID-19

Details and patient eligibility

About

Manual noninvasive respiratory techniques gained interest to treat respiratory pathologies related to COVID 19. This study designed to determine the combined effect of manual diaphragmatic release technique with the effect of conventional breathing exercises and prone positioning on pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).

Full description

Forty females were randomly assigned to two groups. Group A received manual diaphragm release with conventional breathing exercises and prone positioning. Group B received conventional breathing exercises and prone positioning. Both groups took their prescribed medications. Their ages ranged from 35 to 45 years and with moderate COVID-19 illness. Any cases with mild and severe COVID-19 illness, ICU admission, and chest diseases were excluded.

Main measures: pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).

Enrollment

40 patients

Sex

Female

Ages

35 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women with moderate COVID-19 illness diagnosed by a physician.
  • Patients with o2 saturation >94%Nonsmoker subjects.
  • age ranging from 35-45 years.
  • body mass index from 25 to 34 kg/m2.

Exclusion criteria

  • Unstable hemodynamic status.
  • Acute respiratory failure requiring intubation and impaired consciousness.
  • Inability to collaborate with prone positioning with refusal.
  • Change of mental status hindering response to instructions.
  • Poorly controlled hypertension (Mean systolic BP > 140 mmhg and \or diastolic BP > 40 mmhg).
  • Patients who take continuous o2 supplementation.
  • Smoking.
  • Other chest diseases as (COPD-asthma-tuberculosis-cancer).
  • Male patients.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

Study group
Experimental group
Description:
they received manual diaphragm release with conventional breathing exercises and prone positioning in addition to their prescribed medications.
Treatment:
Other: manual therapy
Other: breathing exercise and prone position alone
Control group
Active Comparator group
Description:
they received conventional breathing exercises and prone positioning alone in addition to their prescribed medications.
Treatment:
Other: breathing exercise and prone position alone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems